Faeth Therapeutics Statistics

Total Valuation

FTH has a market cap or net worth of $589.56 million. The enterprise value is $387.81 million.

Market Cap	589.56M
Enterprise Value	387.81M

Important Dates

The next estimated earnings date is Wednesday, August 5, 2026.

Earnings Date	Aug 5, 2026
Ex-Dividend Date	n/a

Share Statistics

FTH has 25.78 million shares outstanding. The number of shares has increased by 0.96% in one year.

Current Share Class	25.78M
Shares Outstanding	25.78M
Shares Change (YoY)	+0.96%
Shares Change (QoQ)	+2.67%
Owned by Insiders (%)	4.06%
Owned by Institutions (%)	8.69%
Float	22.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.39

Current Ratio	14.39
Quick Ratio	14.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5,801.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-95.24%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-97.10%
Weighted Average Cost of Capital (WACC)	2.98%
Revenue Per Employee	n/a
Profits Per Employee	-$6.36M
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +166.09% in the last 52 weeks. The beta is -0.23, so FTH's price volatility has been lower than the market average.

Beta (5Y)	-0.23
52-Week Price Change	+166.09%
50-Day Moving Average	21.53
200-Day Moving Average	16.79
Relative Strength Index (RSI)	60.00
Average Volume (20 Days)	89,886

Short Selling Information

The latest short interest is 798,278, so 3.10% of the outstanding shares have been sold short.

Short Interest	798,278
Short Previous Month	815,539
Short % of Shares Out	3.10%
Short % of Float	3.54%
Short Ratio (days to cover)	23.85

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-185.64M
Pretax Income	-184.46M
Net Income	-184.46M
EBITDA	-185.51M
EBIT	-185.64M
Earnings Per Share (EPS)	-$145.28

Full Income Statement

Balance Sheet

The company has $202.79 million in cash and $1.04 million in debt, giving a net cash position of $201.75 million or $7.83 per share.

Cash & Cash Equivalents	202.79M
Total Debt	1.04M
Net Cash	201.75M
Net Cash Per Share	$7.83
Equity (Book Value)	-137.29M
Book Value Per Share	-102.43
Working Capital	190.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.09 million and capital expenditures -$22,000, giving a free cash flow of -$24.11 million.

Operating Cash Flow	-24.09M
Capital Expenditures	-22,000
Depreciation & Amortization	135,000
Net Borrowing	-641,000
Free Cash Flow	-24.11M
FCF Per Share	-$0.94

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.96%
Shareholder Yield	-0.96%
Earnings Yield	-31.29%
FCF Yield	-4.09%

Analyst Forecast

The average price target for FTH is $54.50, which is 138.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$54.50
Price Target Difference	138.30%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2